Notice of Change in Key Dates and Award Information for RFA-HL-21-013 "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)"
Notice Number:
NOT-HL-21-012

Key Dates

Release Date:

June 18, 2021

Related Announcements

RFA-HL-21-013 - Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)

Issued by

National Heart, Lung, and Blood Institute (NHLBI)

Purpose

The purpose of this Notice is to alert potential applicants to a change in Key Dates and Award Information for RFA-HL-21-013, "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)".

The following sections of RFA-HL-21-013, "Disease Modifying Therapies for Chronic Lung Disease (R61/R33 Clinical Trial Required)" have been modified:

Part 1. Key Dates
 

Currently Reads:

Open Date (Earliest Submission Date)

June 24, 2020

Letter of Intent Due Date(s)

30 days prior to the application due date
Application Due Date(s)

July 24, 2020, March 19, 2021, June 1, 2022.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s) Not Applicable
Scientific Merit Review December 2020, April 2021, January 2023
Advisory Council Review January 2021, May 2021, January 2023
Earliest Start Date April 2021, August 2021, April 2023
Expiration Date June 02, 2022


Modified to Read (changes shown in bold italics):

Open Date (Earliest Submission Date) June 24, 2020
Letter of Intent Due Date(s) 30 days prior to the application due date
Application Due Date(s)

July 24, 2020, March 19, 2021, January 10, 2022, June 1, 2022.

All applications are due by 5:00 PM local time of applicant organization. All types of non-AIDS applications allowed for this funding opportunity announcement are due on the listed date(s).

Applicants are encouraged to apply early to allow adequate time to make any corrections to errors found in the application during the submission process by the due date.

AIDS Application Due Date(s) Not Applicable
Scientific Merit Review December 2020, April 2021, April 2022November 2022
Advisory Council Review January 2021, May 2021, May 2022, January 2023
Earliest Start Date April 2021, August 2021, July 2022,  April 2023
Expiration Date June 02, 2022


Part 2. Section II. Award Information
 

Currently Reads:

Funds Available and Anticipated Number of Awards

NHLBI intends to commit total costs up to $630,000 in FY2021, $315,000 in FY2022, and $630,000 in FY2023 to fund up to two new awards in FY2021, one in FY2022, and two in FY2023. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Award Budget

Application budgets may not exceed direct costs of $200,000 per year. Actual budget amounts will depend on annual appropriations.

Investigators are encouraged to request what is well-justified for their research program.

Modified to Read (changes shown in bold italics):

Funds Available and Anticipated Number of Awards

NHLBI intends to commit total costs up to $900,000 in FY2022, and $450,000 in FY2023, to fund up to two new awards in FY2022, one in FY2023. The number of awards is contingent upon NIH appropriations and the submission of a sufficient number of meritorious applications.

Award Budget

Application budgets may not exceed direct costs of $270,000 per year. Actual budget amounts will depend on annual appropriations.

Investigators are encouraged to request what is well-justified for their research program.

All other aspects of this FOA remain unchanged.

Inquiries

Please direct all inquiries to:

Antonello Punturieri, MD, PhD
Division of Lung Diseases
National Heart, Lung, and Blood Institute (NHLBI)
Telephone: 301-435-0233
Email: punturieria@nhlbi.nih.gov


Weekly TOC for this Announcement
NIH Funding Opportunities and Notices